References:
  1. Silveira LMVD, Tagliari AP, Costa RDD, Martins CB and Wender O.: Aortic Valve Replacement Combined with Ascending Aortic Aneurysmectomy in a Patient with Sickle Cell Disease: a Case Report. Braz J Cardiovasc Surg . 2018; 33(2):203–205. doi:10.21470/1678-9741-2017-0185
  2. Yousafzai SM, Ugurlucan M, Al Radhwan OA, Al Otaibi AL and Canver CC: Open heart surgery in patients with sickle cell hemoglobinopathy.Circulation . 2010; 121 : 14–19.
  3. Edwin F, Aniteye E, Tettey M, Tamatey M, Entsua-Mensah K, Ofosu-Appiah E, Sereboe L,   Gyan B, Adzamli I and Frimpong-Boateng K: Hypothermic cardiopulmonary bypass without exchange transfusion in sickle-cell patients: a matched-pair analysis. Interactive cardiovascular and thoracic surgery. 2014; 19(5):771–776.
  4. Moutaouekkil el M, Najib A, Ajaja R, Arji M and Slaoui A.: Heart valve surgery in patients with homozygous sickle cell disease: A management strategy. Ann Card Anaesth . 2015;18(3):361–366.
  5. Crawford TC, Carter MV, Patel RK, Suarez-Pierre A1, Lin SZ1, Magruder JT1, Grimm JC1, Cameron DE1, Baumgartner WA1 and Mandal K1: Management of sickle cell disease in patients undergoing cardiac surgery. J Card Surg . 2017; 32(2):80–84.
  6. Elmahrouk AF, Ismail MFC, Bugis A, Badawy N, Aboelghar HM, Hamouda TE and Jamjoom. AA: Staged Surgical Palliation for HLHS in a Girl with Severe Factor X Deficiency. Thorac Cardiovasc Surg Rep 2018; 7:e12–e15.
  7. 7-Ewila H, Eltigani A, Abdelaziz A, Badr A, Kindawi A and Ahmed ElmahrouK: Preoperative hemoglobin concentration as an independent predictor for outcome after coronary artery bypass grafting. Journal of the Egyptian Society of Cardio-thoracic Surgery 24 (2016) 265-69